Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients: a Cohort Study

NCT04600219 is registered in ClinicalTrials.gov with Ai Peng as lead sponsor.

NCT NCT04600219
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04600219 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Tyrosine Kinase Receptor Axl on Dialysis Prognosis in Chronic Hemodialysis Patients: a Cohort Study
Lead sponsor
Ai Peng
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2018
Completion date
December 1, 2021
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis complication